265 related articles for article (PubMed ID: 24567787)
1. Brain stem cells as the cell of origin in glioma.
Modrek AS; Bayin NS; Placantonakis DG
World J Stem Cells; 2014 Jan; 6(1):43-52. PubMed ID: 24567787
[TBL] [Abstract][Full Text] [Related]
2. Developmental origins and oncogenic pathways in malignant brain tumors.
Lu QR; Qian L; Zhou X
Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
[TBL] [Abstract][Full Text] [Related]
3. The Updated World Health Organization Glioma Classification: Cellular and Molecular Origins of Adult Infiltrating Gliomas.
Pisapia DJ
Arch Pathol Lab Med; 2017 Dec; 141(12):1633-1645. PubMed ID: 29189064
[TBL] [Abstract][Full Text] [Related]
4. Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
Muñoz DM; Tung T; Agnihotri S; Singh S; Guha A; Zadeh G; Hawkins C
Glia; 2013 Nov; 61(11):1862-72. PubMed ID: 24038521
[TBL] [Abstract][Full Text] [Related]
5. On the origin of glioma.
Jiang Y; Uhrbom L
Ups J Med Sci; 2012 May; 117(2):113-21. PubMed ID: 22348397
[TBL] [Abstract][Full Text] [Related]
6. Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression.
Fomchenko EI; Dougherty JD; Helmy KY; Katz AM; Pietras A; Brennan C; Huse JT; Milosevic A; Holland EC
PLoS One; 2011; 6(7):e20605. PubMed ID: 21754979
[TBL] [Abstract][Full Text] [Related]
7. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
8. Modeling Glioma with Human Embryonic Stem Cell-Derived Neural Lineages.
Modrek AS; Prado J; Bready D; Dhaliwal J; Golub D; Placantonakis DG
Methods Mol Biol; 2018; 1741():227-237. PubMed ID: 29392705
[TBL] [Abstract][Full Text] [Related]
9. Glioma stem cells: evidence and limitation.
Fan X; Salford LG; Widegren B
Semin Cancer Biol; 2007 Jun; 17(3):214-8. PubMed ID: 16750389
[TBL] [Abstract][Full Text] [Related]
10. Origin of Gliomas.
Cahill D; Turcan S
Semin Neurol; 2018 Feb; 38(1):5-10. PubMed ID: 29548046
[TBL] [Abstract][Full Text] [Related]
11. Revisit the Candidacy of Brain Cell Types as the Cell(s) of Origin for Human High-Grade Glioma.
Shao F; Liu C
Front Mol Neurosci; 2018; 11():48. PubMed ID: 29515370
[TBL] [Abstract][Full Text] [Related]
12. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis.
Aguado T; Carracedo A; Julien B; Velasco G; Milman G; Mechoulam R; Alvarez L; Guzmán M; Galve-Roperh I
J Biol Chem; 2007 Mar; 282(9):6854-62. PubMed ID: 17202146
[TBL] [Abstract][Full Text] [Related]
14. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.
Thirant C; Bessette B; Varlet P; Puget S; Cadusseau J; Tavares Sdos R; Studler JM; Silvestre DC; Susini A; Villa C; Miquel C; Bogeas A; Surena AL; Dias-Morais A; Léonard N; Pflumio F; Bièche I; Boussin FD; Sainte-Rose C; Grill J; Daumas-Duport C; Chneiweiss H; Junier MP
PLoS One; 2011 Jan; 6(1):e16375. PubMed ID: 21297991
[TBL] [Abstract][Full Text] [Related]
16. A computational model incorporating neural stem cell dynamics reproduces glioma incidence across the lifespan in the human population.
Bauer R; Kaiser M; Stoll E
PLoS One; 2014; 9(11):e111219. PubMed ID: 25409511
[TBL] [Abstract][Full Text] [Related]
17. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
[TBL] [Abstract][Full Text] [Related]
19. Targeting glioma stem cells: enough to terminate gliomagenesis?
Dong J; Huang Q
Chin Med J (Engl); 2011 Sep; 124(17):2756-63. PubMed ID: 22040437
[TBL] [Abstract][Full Text] [Related]
20. GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma.
Abel TW; Clark C; Bierie B; Chytil A; Aakre M; Gorska A; Moses HL
Mol Cancer Res; 2009 May; 7(5):645-53. PubMed ID: 19435821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
